Key result
Combined Tbx3 and Tbx5 deficiency in the murine ventricular conduction system caused conduction defects, prolonged PR and QRS intervals, and elevated susceptibility to ventricular tachycardia.
Why the study?
TBX3 and TBX5 are required for cardiac conduction system development and associated with human conduction diseases, but their coordinated role in the adult ventricular conduction system required evaluation.
Does combined Tbx3 and Tbx5 deficiency alter ventricular conduction system molecular fate and function in a murine model?
Does combined Tbx3 and Tbx5 deficiency alter ventricular conduction system molecular fate and function in a murine model?
Tbx3 and Tbx5 coordinate to control the molecular fate and function of the ventricular conduction system, providing mechanistic insights into cardiac conduction disorders.
May inform mechanisms of murine conduction defects; leaves open translation to human arrhythmias.
The cardiac conduction system (CCS) orchestrates the electrical impulses that enable coordinated contraction of the cardiac chambers. The T-box transcription factors TBX3 and TBX5 are required for cardiac conduction system development and associated with overlapping and distinct human cardiac conduction system diseases. We evaluated the coordinated role of Tbx3 and Tbx5 in the murine ventricular conduction system (VCS). We engineered a compound Tbx3:Tbx5 conditional knockout allele for both genes located in cis on mouse chromosome 5. Conditional deletion of both T-box transcriptional factors in the ventricular conduction system, using the VCS-specific MinK:Cre, caused loss of VCS function and molecular identity. Combined Tbx3 and Tbx5 deficiency in the adult VCS led to conduction defects, including prolonged PR and QRS intervals and elevated susceptibility to ventricular tachycardia. These electrophysiological defects occurred prior to detectable alterations in cardiac contractility or histologic morphology, indicative of a primary conduction system defect. Tbx3:Tbx5 double knockout VCS cardiomyocytes revealed a transcriptional shift towards non-CCS-specialized working myocardium, indicating a change to their cellular identity. Furthermore, optical mapping revealed a loss of VCS-specific conduction system propagation. Collectively, these findings indicate that Tbx3 and Tbx5 coordinate to control VCS molecular fate and function, with implications for understanding cardiac conduction disorders in humans.
No takes yet. Share an insight, caveat, or question.
Burnicka-Turek et al. (2025) studied Cardiac conduction system diseases. Compound Tbx3:Tbx5 conditional knockout was evaluated on Ventricular conduction system function and molecular identity. Combined Tbx3 and Tbx5 deficiency in the murine ventricular conduction system caused conduction defects, prolonged PR and QRS intervals, and elevated susceptibility to ventricular tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: